COMPASS Pathways plc CMPS
- psilocybin — Treatment-Resistant Depression NDA Submitted
- psilocybin — Post-Traumatic Stress Disorder Phase 2
- psilocybin — Anorexia Nervosa Phase 2
Home › Targets › 5-HT2A receptor
5-HT2A receptor (1 companies · 3 programs)
Companies with an active program directed at 5-HT2A receptor.